Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 68 citing articles:

Tamarindus indica Extract as a Promising Antimicrobial and Antivirulence Therapy
Mohamed Ghaly, Marzough Aziz Albalawi, Mahmoud M. Bendary, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 464-464
Open Access | Times Cited: 9
Protective Effects of Mirazid on Gentamicin-induced Nephrotoxicity in Rats through Antioxidant, Anti-inflammatory, JNK1/ iNOS, and Apoptotic Pathways; Novel Mechanistic Insights
Samar A. Antar, Ahmed A. Al‐Karmalawy, Ahmed Mourad, et al.
Pharmaceutical Sciences (2022)
Open Access | Times Cited: 16
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization
Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. Abbas, et al.
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 563-580
Open Access | Times Cited: 8
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations
Fatma G. Abdulrahman, Hamada S. Abulkhair, Riham A. Zidan, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 2, pp. 105-123
Closed Access | Times Cited: 2
Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays
Faten Farouk, Ibrahim M. Ibrahim, Salma Sherif, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 3
Closed Access | Times Cited: 2
Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights
Dalia S. El‐Gamil, Mohamed Y. Zaky, Patrick M. Maximous, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Closed Access | Times Cited: 2
Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation
Asmaa S. A. Yassen, Sherief M. Abdel‐Wahab, Khaled M. Darwish, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 12, pp. 4039-4067
Closed Access | Times Cited: 2
Potential topoisomerases inhibitors from Aspergillus terreus using virtual screening
Eman Zekry Attia, Basma Ali Khalifa, Gehan M. Shaban, et al.
South African Journal of Botany (2022) Vol. 149, pp. 632-645
Open Access | Times Cited: 14
Glimepiride ameliorates renal toxicity induced by cadmium in mice: Modulation of Jun N terminal kinase (JNK)/nuclear factor kappa B (NF-κB) and phosphatidylinositol 3-kinases (PI3K)/protein kinase (AKT) pathways
Mohamed Kh. ElMahdy, Mennatallah O. Zaki, Ahmed A. Al‐Karmalawy, et al.
Life Sciences (2022) Vol. 311, pp. 121184-121184
Closed Access | Times Cited: 14
Inhibition of albendazole and 2‐(2‐aminophenyl)‐1H‐benzimidazole against tyrosinase: mechanism, structure–activity relationship, and anti‐browning effect
Yi‐Ting Wen, Yujia Zhang, Xiaoli Zhang, et al.
Journal of the Science of Food and Agriculture (2023) Vol. 103, Iss. 6, pp. 2824-2837
Closed Access | Times Cited: 7
Aryl Hydrocarbon Receptor as an Anticancer Target: An Overview of Ten Years Odyssey
Hamza Hanieh, Mohammad Bani Ismail, Manal A. Alfwuaires, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 3978-3978
Open Access | Times Cited: 7
Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
Howaida I. Abd‐Alla, Omnia Kutkat, Heba-tollah M. Sweelam, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1109-1109
Open Access | Times Cited: 12
Taming Food–Drug Interaction Risk: Potential Inhibitory Effects of Citrus Juices on Cytochrome Liver Enzymes Can Safeguard the Liver from Overdose Paracetamol-Induced Hepatotoxicity
Aya S. Shalaby, Hanaa H. Eid, Riham A. El‐Shiekh, et al.
ACS Omega (2023) Vol. 8, Iss. 29, pp. 26444-26457
Open Access | Times Cited: 6
Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFRWT and EGFRT790M with ADMET Profiling
Nilesh Raghunath Khedkar, Milind Sindkhedkar, Alex Joseph
Bioorganic Chemistry (2023) Vol. 143, pp. 107027-107027
Closed Access | Times Cited: 6
Investigation of benzimidazole anthelmintics as oral anticancer agents
Jiyoon Jang, Kwang‐Ho Lee, Byumseok Koh
Bulletin of the Korean Chemical Society (2022) Vol. 43, Iss. 5, pp. 750-756
Open Access | Times Cited: 10
Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR‐2 Inhibitors and Endowed with Apoptotic Potential
Norhan Eid, Ahmed A. Al‐Karmalawy, Taha M. A. Eldebss, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 1
Throat spray formulated with virucidal pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS-CoV-2
Amira A. Boseila, Doaa A. Ghareeb, M.A. Wahab, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 199, pp. 114279-114279
Closed Access | Times Cited: 1
Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies
Rogy R. Ezz Eldin, Marwa A. Saleh, Sefat Alwarsh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1247-1247
Open Access | Times Cited: 5
Sulfate glycosaminoglycan from swim bladder exerts immunomodulatory potential on macrophages via toll-like receptor 4 mediated NF-κB signaling pathways
Kun Yang, Xuejing Jia, Jing Chen, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132439-132439
Closed Access | Times Cited: 1
Boosting the Anti‐Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations
Mahmoud M. Bendary, Arwa R. Elmanakhly, Farag M. Mosallam, et al.
Helicobacter (2024) Vol. 29, Iss. 4
Closed Access | Times Cited: 1
In Silico Screening of FDA‐Approved Anthelmintic Drugs Against LuxR Protein as Quorum‐Sensing Inhibitors and Exploration of Their Binding Mechanism and Electronics Properties
Uttam Paswan, Hriday Kumar Basak, Soumen Saha, et al.
ChemistrySelect (2024) Vol. 9, Iss. 40
Closed Access | Times Cited: 1
Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach
Hanin A. Bogari, Sameh S. Elhady, Khaled M. Darwish, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 162-162
Open Access | Times Cited: 4
Phytochemical Characterization of Pterocephalus frutescens with In-Silico Evaluation as Chemotherapeutic Medicine and Oral Pharmacokinetics Prediction Study
Atef A. El‐Hela, Marwa S. Abu Bakr, Mostafa M. Hegazy, et al.
Scientia Pharmaceutica (2023) Vol. 91, Iss. 1, pp. 7-7
Open Access | Times Cited: 4
Antimicrobial potential of phytocompounds ofAcorus calamus: in silicoapproach
Kumari Shalini, Shikha Guleria, Deeksha Salaria, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 5, pp. 2726-2737
Closed Access | Times Cited: 4
Integrating biocomputational techniques for Breast cancer drug discovery via the HER-2, BCRA, VEGF and ER protein targets
Tope T. Odunitan, Oluwatosin A. Saibu, Boluwatife T. Apanisile, et al.
Computers in Biology and Medicine (2023) Vol. 168, pp. 107737-107737
Closed Access | Times Cited: 4

Scroll to top